SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-031256
Filing Date
2023-03-10
Accepted
2023-03-10 17:02:08
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm239005d1_s3.htm S-3 192737
2 EXHIBIT 5.1 tm239005d1_ex5-1.htm EX-5.1 12792
3 EXHIBIT 23.1 tm239005d1_ex23-1.htm EX-23.1 2709
4 EXHIBIT 107 tm239005d1_ex-filingfees.htm EX-FILING FEES 13897
5 GRAPHIC tm239005d1_s3img001.jpg GRAPHIC 14173
6 GRAPHIC tm239005d1_s3img002.jpg GRAPHIC 14196
7 GRAPHIC image_001.jpg GRAPHIC 3142
  Complete submission text file 0001104659-23-031256.txt   266949
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-270474 | Film No.: 23724565
SIC: 2834 Pharmaceutical Preparations